Synthetic biology is the “third biotechnology revolution” leading the world after the two biotechnology revolutions of “DNA double helix discovery” and “Human Genome Project”. “The discovery of the DNA double helix” and the “Human Genome Project” enabled human beings to realize the transition from knowing life to interpreting life. As a disruptive technology in the field of life sciences in the 21st century, synthetic biology has promoted the leap from interpreting life to programming life and creating life.

Synthetic biology, as a comprehensive discipline, has been widely used in the fields of new drug development, agricultural production, material synthesis, environmental protection, energy supply, and new material development. It will also promote global biomedicine, agricultural innovation, innovation and development for energy security, and climate issues.

Thereafter, under the academic guidance of China National Biomedical Technology Innovation Center and other institutions, with the assistance and support of international organizations such as the Asian Synthetic Biology Association (ASBA), MyBioGate and the CUBIO Innovation Center is organizing the “2023 The Global Synthetic Biology Conference” in Shanghai, China on October 25-26.

This conference is a global event in the field of synthetic biology. The organizer will invite organizations from Chinese and foreign synthetic biology associations, experts from well-known Chinese and foreign universities and research institutions, executives from European, American and Chinese synthetic biology companies, and Chinese and foreign synthetic biology investment and financing institutions to participate. At the same time, the theme of our conference will focus on topics such as the application of global cutting-edge synthetic biology technology, industry policy guidance and future development trends, and the investment and financing status of the global synthetic biology industry, in order to seek an all-round development plan for synthetic biology technology.